The antihypertensive action of beta-adrenoceptor blocking agents
Conway, J.
Archives Internationales de Pharmacodynamie et de Therapie Suppl: 83-91
1980
ISSN/ISBN: 0003-9780 PMID: 6106461 Document Number: 160648
The fall in blood pressure after the induction of beta-blockade occurs approximately 3 hours after the fall in cardiac output, heart rate and plasma renin activity has occurred. None of the known pharmacological actions of these agents can directly account for the fall in pressure. Further work is required to determine whether the fall in cardiac output is essential or whether these agents affect renal handling of sodium. Studies are also needed of baroceptor function as blood pressure falls.
Document emailed within 1 workday
Related Documents
Miyagishi, A.; Nakahara, H.; Hara, Y. 1984: Adrenoceptor blocking effects of arotinolol, a new combined alpha- and beta-adrenoceptor blocking agent Archives Internationales de Pharmacodynamie et de Therapie 271(2): 249-262Mostaghim, R.; Maddox, Y.T.; Ramwell, P.W. 1986: Endothelial potentiation of relaxation response to beta adrenoceptor blocking agents Journal of Pharmacology and Experimental Therapeutics 239(3): 797-801
Hellenbrecht, D.; Gortner, L. 1976: Correlations between hydrophobicity and non-specific pharmacological effects of beta-adrenoceptor blocking agents Polish Journal of Pharmacology and Pharmacy 28(6): 625-630
Schneider, R.E.; Bishop, H.; Kendall, M.J.; Quarterman, C.P. 1981: Effect of inflammatory disease on plasma concentrations of three beta-adrenoceptor blocking agents International Journal of Clinical Pharmacology Therapy and Toxicology 19(4): 158-162
Chu, D.; Hofmann, A.; Stürmer, E. 1978: Anaesthetised normotensive rats for the detection of hypotensive activity of a beta-adrenoceptor antagonist and other antihypertensive agents Arzneimittel-Forschung 28(11): 2093-2097
Schulte, K.L.; Meyer-Sabellek, W.; Thiede, H.M.; Röcker, L.; Gotzen, R. 1987: Beta-adrenoceptor stimulating and blocking agents in essential hypertension: single and combined therapy with terbutaline and metoprolol International Journal of Clinical Pharmacology Therapy and Toxicology 25(10): 539-544
Andersen, G.S.; Hartling, O.J.; Hein, H.O.; Leth, A. 1985: Changes in blood pressure, fluid volumes and glomerular filtration rate during long-term treatment with prizidilol, an antihypertensive drug with combined vasodilatator and beta-adrenoceptor blocking actions Danish Medical Bulletin 32(5): 280-283
Leonetti, G.; Sampieri, L.; Cuspidi, C.; Terzoli, L.; Rupoli, L.; Fruscio, M.; Gradnik, R.; Zanchetti, A. 1985: Does beta 1-selective agonistic activity interfere with the antihypertensive efficacy of beta 1-selective blocking agents? Journal of Hypertension. Suppl: Official Journal of the International Society of Hypertension 3(3): S243-S245
Krum, H.; Pillay, P. 1998: New drugs, old drugs. Beta-adrenoceptor blocking agents Medical Journal of Australia 168(5): 232-235
Yamamoto, N.; Nomura, M.; Okubo, K.; Maeda, K.; Goto, T. 1999: Pharmacologic characterization of FR172516: a new combined calcium channel-blocking and beta-adrenoceptor-blocking agent Journal of Cardiovascular Pharmacology 33(4): 587-594
Asano, M.; Uchida, W.; Shibasaki, K.; Terai, M.; Inagaki, O.; Takenaka, T.; Matsumoto, Y.; Fujikura, T. 1990: Pharmacological profiles of YM-16151-1 and its optical isomers: a novel calcium entry blocking and selective beta-1 adrenoceptor blocking agent Journal of Pharmacology and Experimental Therapeutics 254(1): 204-211
Mouillé, P.; Cheymol, G. 1973: Action of various beta adrenolytic agents on the alpha blocking properties of yohimbine in the dog Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales 167(3): 440-442
Krikler, D.M. 1988: Uses of calcium channel blocking agents and beta blocking agents in the control of supraventricular arrhythmias Progress in Clinical and Biological Research 275: 301-317
Mazurowa, A.; Szadowska, A.; Szmigielski, A. 1972: Combined action on the heart of beta adrenergic blocking agents and anti-arrhythmia drugs Kardiologia Polska 15(2): 167-175
Dahlöf, B.; Andrén, L.; Svensson, A.; Hansson, L. 1983: Antihypertensive mechanism of beta-adrenoceptor antagonism--the role of beta 2-blockade Journal of Hypertension. Suppl: Official Journal of the International Society of Hypertension 1(2): 112-115
Rostan, A. 1978: Effects of tolamolol and bufuralol on the arterial blood pressure and plasma renin activity. Contribution to the study of beta-blocking agents action mechanisms Schweizerische Rundschau für Medizin Praxis 67(1): 27-35
Lorimer, A.R.; Jones, J.V.; Clark, B.; Dunn, F.G.; Melville, D.; Lawrie, T.D. 1976: Indications for beta-adrenoceptor blocking drugs in hypertension Postgraduate Medical Journal 52(Suppl 4): 81-85
Conde, S.; Corral, C.; Lissavetzky; Darias, V.; Martin, D. 1986: Synthesis and beta-adrenoceptor blocking activity of thiophenic analogues of metoprolol Il Farmaco; Edizione Scientifica 41(1): 80-88
Shibasaki, K.; Uchida, W.; Shirai, Y.; Inagaki, O.; Asano, M.; Takenaka, T. 1994: Pharmacological properties of YM-15430-1, a 1,4-dihydropyridine derivative with beta 1-adrenoceptor-blocking activity Archives Internationales de Pharmacodynamie et de Therapie 328(2): 213-224
Keith, R.A.; Hwang, T.F.; Murthy, V.S.; Kau, S.T.; Salama, A.I.; Giles, R.E. 1989: ICi 147,798: a slowly dissociable beta adrenoceptor antagonist that causes insurmountable beta-1 and surmountable beta-2 adrenoceptor antagonism in isolated tissues Journal of Pharmacology and Experimental Therapeutics 248(1): 240-248